Emicizumab ' Life-Changing ' for Hemophilia A With Inhibitors Emicizumab ' Life-Changing ' for Hemophilia A With Inhibitors

Emicizumab prophylaxis, recently approved for adult and pediatric patients with hemophilia A with inhibitors to factor VIII, has additional support from the HAVEN 2 study in pediatric patients.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news